Unknown

Dataset Information

0

Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum.


ABSTRACT: We report here a novel anti-cancer therapy based on an avian-host-specific serotype Salmonella enterica serovar Gallinarum (S. Gallinarum) deficient in ppGpp synthesis. To monitor the tumor targeting, a bioluminescent ΔppGpp S. Gallinarum was constructed and injected intravenously into mice bearing syngeneic and human xenograft tumors. Strong bioluminescent signals were detected specifically in all grafted tumors at 2 days post-injection (dpi). The bacterial counts in normal and tumor tissue at 1 dpi revealed that ΔppGpp S. Gallinarum reached >108 CFU/g in tumor tissue and 106-107 CFU/g in endothelial organs; counts were much lower in other organs. At 16 dpi, ΔppGpp S. Gallinarum counts in tumor tissue decreased to ∼106 CFU/g, while those in the other organs became undetectable. A strong anti-cancer effect was observed after the injection of ΔppGpp S. Gallinarum into BALB/c mice grafted with CT26 colon cancer cells. This could be attributed to reduced virulence, which allowed the administration of at least a 10-fold greater dose (108 CFU) of ΔppGpp S. Gallinarum than other attenuated strains of S. enterica serovar Typhimurium (≤107 CFU). An advantage of the avian-specific S. Gallinarum as a cancer therapeutic should be a reduced capacity to cause infections or harm in humans.

SUBMITTER: Lim D 

PROVIDER: S-EPMC10694566 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bacterial cancer therapy using the attenuated fowl-adapted <i>Salmonella enterica</i> serovar Gallinarum.

Lim Daejin D   Kim Kwangsoo K   Duysak Taner T   So EunA E   Jeong Jae-Ho JH   Choy Hyon E HE  

Molecular therapy oncolytics 20231102


We report here a novel anti-cancer therapy based on an avian-host-specific serotype <i>Salmonella enterica</i> serovar Gallinarum (<i>S. Gallinarum</i>) deficient in ppGpp synthesis. To monitor the tumor targeting, a bioluminescent ΔppGpp <i>S. Gallinarum</i> was constructed and injected intravenously into mice bearing syngeneic and human xenograft tumors. Strong bioluminescent signals were detected specifically in all grafted tumors at 2 days post-injection (dpi). The bacterial counts in normal  ...[more]

Similar Datasets

| S-EPMC4767912 | biostudies-literature
| S-EPMC6486240 | biostudies-literature
| S-EPMC2583507 | biostudies-literature
| S-EPMC8375982 | biostudies-literature
| S-EPMC7556571 | biostudies-literature
| S-EPMC4453544 | biostudies-literature
| S-EPMC7677237 | biostudies-literature
| S-EPMC3931352 | biostudies-literature
| S-EPMC6449608 | biostudies-literature
| S-EPMC9485580 | biostudies-literature